Depression

September 23rd 2024

Studies conducted in Taiwan and the United Kingdom have added to. the evidence that inherited genes play a prominent role in the development of treatment-resistant depression.

September 22nd 2024

Spravato is a derivative of the anesthetic ketamine.

September 19th 2024

Independence Blue Cross has increased local provider options by 47% since 2022, and now offers additional mental health and substance abuse services.

September 17th 2024

The FDA rejected an application to approve MDMA, also known as ecstasy, as a treatment for PTSD. Next up among the psychedelics vying for FDA approval: psilocybin for treatment resistant depression.